Market Highlights:
Mycoplasma testing market used to detect contamination in given biologic samples. The mycoplasma testing market size was valued USD 798.7 million in 2021 and is expected to reach USD 2.18 billion by 2030 at 13.9% CAGR during the forecast period 2022-2030.
Increasing R&D investment and new product launches are expected to drive the growth of the market. According to the Center for Drug Evaluation and Research, in 2022, about 46 novel drug approvals were the 22 novel drug approvals in 2016. On other hand, the availability of alternative traditional methods can restrain the market growth over the assessment period.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/1216
Key Players:
Some of the prominent players in the global mycoplasma testing market are Charles River Laboratories, Inc., Merck KGaA, Lonza Group Ltd, Roche Diagnostics, SGS S.A., American Type Culture Collection, Invivogen, Wuxi Apptec, Promocell GmbH, and Thermo Fisher Scientific Inc,.
Regional Analysis:
Geographically, the Americas is expected to dominate the global market owing to the presence of well-established players and growth in pharmaceutical and medical device companies. Europe is expected to hold the second largest position in the global market. Asia-Pacific is expected to be the fastest growing market owing to the increasing adoption of the technologies. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global market.
Segmentation:
The global mycoplasma testing market has been segmented into product, Technique, application, and end user.
Based on product, market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is expected to account for the largest share and fastest growing segment of the global market in 2022.
Based on technique, market is segmented into Enzyme-based, PCR, ELISA, Direct Assay, Indirect Assay, Others.
Based on application, it has been segmented into cell line and cell therapy testing, virus testing, row material testing, lot release testing, and others.
Based on end user, has been segmented into pharmaceutical and biological manufacturing, contract research organizations, cell banks, and others
Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/mycoplasma-testing-market-6776
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team has the supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
